Literature DB >> 7753708

Spontaneous metastasis of PC-3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments.

D J Waters1, E B Janovitz, T C Chan.   

Abstract

The ability of subcutaneous, prostatic, and nonprostatic intraabdominal organ microenvironments to influence local tumor growth and metastasis of PC-3 human prostate carcinoma cells in athymic mice was determined. Tumorigenesis and metastasis of PC-3 were evaluated 60 days after subcutaneous and intraprostatic (orthotopic) implantation of 5 x 10(5) PC-3 cells in 6-week-old, male athymic mice. Intraprostatic implantation of PC-3 cells resulted in paraaortic lymph node metastases in 10 of 10 (100%) mice with prostatic tumors, whereas metastases were present in only 2 of 9 (22%) mice after subcutaneous implantation. Next, we determined whether the urinary bladder (nonprostatic, urogenital microenvironment) or stomach (nonurogenital, intraabdominal microenvironment) would facilitate the metastasis of PC-3 cells in athymic mice. Tumorigenesis and metastasis were 100% after subserosal implantation of PC-3 cells within the wall of the urinary bladder (n = 6 mice). Subserosal implantation of PC-3 cells into the stomach wall (n = 7 mice) also resulted in tumor formation and metastasis to regional lymph nodes in 100% of mice. In all experiments, regional lymph nodes were the most frequent site of metastasis, regardless of implantation site. We conclude that tumor microenvironment factors responsible for the metastasis of PC-3 cells in athymic mice may not be organ-specific, since nonprostatic visceral microenvironments are sufficient for predictable metastasis. Use of these models may further our understanding of how tumor microenvironment modulates expression of the metastatic phenotype by human prostate carcinoma cells.

Entities:  

Mesh:

Year:  1995        PMID: 7753708     DOI: 10.1002/pros.2990260502

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

Review 1.  New cast for a new era: preclinical cancer drug development revisited.

Authors:  Grit S Herter-Sprie; Andrew L Kung; Kwok-Kin Wong
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.

Authors:  Marie-France Penet; Samata Kakkad; Arvind P Pathak; Balaji Krishnamachary; Yelena Mironchik; Venu Raman; Meiyappan Solaiyappan; Zaver M Bhujwalla
Journal:  Clin Cancer Res       Date:  2016-10-31       Impact factor: 12.531

3.  Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.

Authors:  Marta Vilalta; Nicholas P Hughes; Rie Von Eyben; Amato J Giaccia; Edward E Graves
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

4.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

5.  Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.

Authors:  M E Laniado; E N Lalani; S P Fraser; J A Grimes; G Bhangal; M B Djamgoz; P D Abel
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

6.  TRAIL-coated leukocytes that prevent the bloodborne metastasis of prostate cancer.

Authors:  Elizabeth C Wayne; Siddarth Chandrasekaran; Michael J Mitchell; Maxine F Chan; Rachel E Lee; Chris B Schaffer; Michael R King
Journal:  J Control Release       Date:  2015-12-28       Impact factor: 9.776

7.  Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Authors:  Marie-France Penet; Arvind P Pathak; Venu Raman; Paloma Ballesteros; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

8.  Metastatic phenotype in CWR22 prostate cancer xenograft following castration.

Authors:  Steven J Seedhouse; Hayley C Affronti; Ellen Karasik; Bryan M Gillard; Gissou Azabdaftari; Dominic J Smiraglia; Barbara A Foster
Journal:  Prostate       Date:  2015-12-08       Impact factor: 4.104

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.